Desmopressin Acetate (DDAVP)
Company: Rhone Poulenc RorerApproval Status: Approved March 1998
Treatment for: nocturnal enuresis
Areas: Pediatrics
Possible similar drugs: Desmopressin Acetate
General Information
A tablet formulation of DDAVP (Desmopressin Acetate) has been approved for managing primary nocturnal enuresis in patients age six and over. DDAVP is a synthetic form of vasopressin that has been available in nasal spray since 1989. Vasopressin regulates water balance and urine production.
Desmopressin Acetate Drug Information
The Desmopressin Acetate drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
